HCXT-2001 / Shanghai Peptidstar Therapeutics - LARVOL DELTA

A Study of HCXT-2001 Tablets and HCXT-2001 Tablets(A) in Healthy Adults (clinicaltrials.gov) - P1 | N=40 | Not yet recruiting | Sponsor: Shanghai Peptidstar Therapeutics Limited

New P1 trial • Dermatology • Immunology • Psoriasis

Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Immunogenicity Profiles of Single Doses of HCXT-2001 Tablets (A) in Healthy Adult Participants, and the Effect of Food on the Pharmacokinetics of HCXT-2001 Tablets (A) (ChiCTR) - P=N/A | N=58 | Not yet recruiting | Sponsor: The Second Hospital of Anhui Medical University; The Second Hospital of Anhui Medical University

New trial • Dermatology • Immunology • Psoriasis